Global Clinical Genomics Market has shown strong growth pattern in recent years majorly due to growing significance on early disease detection and prevention, rising insistence for precision medicine, increasing application of genetic testing in oncology, and favourable reimbursement scenario related to genetic testing are expected to boost the growth of the global clinical genomics market. However, enormous cost and social and ethical implications of genetic testing may obstruct the growth of clinical genomics market to some extent. —
Meticulous Research® in its latest publication on Clinical Genomics Market states that the global clinical genomics market will increase at a CAGR of 17.1% from 2018 to 2023 to reach USD 879.0 million by 2023. Wherein, geographically, North America commanded the largest share in this market followed by Europe. The growth in the North American clinical genomics market is primarily attributed to high burden of chronic and infectious diseases, increasing R&D expenditure, and various government initiatives. However, the Asia-Pacific region is projected to grow at a fastest rate, due to increasing population, rising prevalence of various diseases, availability of funding, and developing healthcare infrastructures in the region.
Request Sample Report: https://www.meticulousresearch.com/request-sample-report/?cp_id=3763
The report provides meticulous analysis of global clinical genomics market by segmenting it on the basis of test type (diagnostic testing, genetic testing, newborn screening, prenatal testing, preimplantation testing, carrier screening and other tests), method (molecular tests, chromosomal tests, biochemical tests), end user (hospitals & clinics, government laboratories & research centers, academics and research institutes and other end users). Wherein, among methods, molecular tests held the largest share in global clinical genomics, owing to the advancement in technology, which helps to detect the single nucleotide resolution with cheaper, faster, and with the utmost accuracy by using whole genome sequencing (WGS), and whole exome sequencing (WES) technology.
The key players analyzed in the global Clinical Genomics Market report are Quest Diagnostics Incorporated (U.S.), Eurofins Scientific SE (Luxembourg), Illumina, Inc. (U.S.), PerkinElmer, Inc. (U.S.), NeoGenomics Inc. (U.S.), Foundation Medicine, Inc. (U.S.), Rosetta Genomics Ltd. (Israel), Invitae Corporation (U.S.), Myriad Genetics, Inc. (U.S.), Natera, Inc. (U.S.), Genomic Health, Inc. (U.S.), OPKO Health, Inc. (U.S.), Centogene AG (Germany), Clinical Genomics Pty Ltd. (Australia), 23andMe, Inc. (U.S.), Iverson Genetic Diagnostics, Inc. (U.S.), Veritas Genetics (U.S.), Gene by Gene, Ltd. (U.S.), GenomeDx Biosciences, Inc. (Canada), MedGenome (India), Strand Life Sciences Pvt. Ltd. (India), Beijing Genomics Institute (BGI) (China), Retrogen, Inc. (U.S.), Personalis, Inc. (U.S.), and PathGroup (U.S.)
Browse in-depth Report on https://www.meticulousresearch.com/product/clinical-genomics-market-forecast-2023/
Key Topics Covered in This Report:
2. Research Methodology
3. Executive Summary
4. Market Share Analysis
5. Market Insights
5. Global Clinical Genomics Market, By Product/Service Type
6. Global Clinical Genomics Market, By Test Type
7. Global Clinical Genomics Market, By Method
8. Global Clinical Genomics Market, By End user
9. Geographic Analysis
10. Competitive Landscape
11. Company Profiles
Don’t miss out on business opportunities in Clinical Genomics Market. Download free sample report and gain crucial industry insights that will help your business grow.
Global Next Generation Sequencing Informatics Market Size by Product & Services, by Function, by Application, by End User – Global Opportunity Analysis and Industry Forecast (2017- 2022)
Browse report @ https://www.meticulousresearch.com/product/ngs-informatics-market-forecast/
Cell Culture Market Size by Product, by Application, and by End User – Global Opportunity Analysis and Industry Forecasts To 2022
Browse report @ https://www.meticulousresearch.com/product/cell-culture-market-size-2022/
About Meticulous Research®
Meticulous Research® is founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
Name: Viren Shrivastava
Email: Send Email
Organization: Meticulous Market Research Pvt. Ltd.
Address: Wembley, Middlesex- HA0 4JH, U.K.
Release ID: 410496